Zimmer Biomet Financials

Zimmer Biomet Stock Summary

Zimmer Biomet competes with Abbott Laboratories, Abbott Laboratories, Medtronic PLC, Stryker, and Boston Scientific. Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. ZIMMER BIOMET operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 19000 people.

Zimmer Biomet Key Financial Ratios

There are many critical financial ratios that Zimmer Biomet's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Zimmer Biomet Holdings reports annually and quarterly.

Zimmer Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zimmer Biomet's current stock value. Our valuation model uses many indicators to compare Zimmer Biomet value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zimmer Biomet competition to find correlations between indicators driving Zimmer Biomet's intrinsic value. More Info.Zimmer Biomet Holdings is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about  1.57  of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zimmer Biomet's earnings, one of the primary drivers of an investment's value.

Zimmer Biomet Holdings Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Zimmer Biomet help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zimmer Biomet Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zimmer Biomet Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Zimmer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zimmer Biomet's daily price indicators and compare them against related drivers.

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.